Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Extends Comment Period for Proposed 503A MOU until July 20, 2015

Wednesday, June 3, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |

The Food and Drug Administration (FDA) is extending the comment period in the notice of availability that originally appeared in the Federal Register of February 19, 2015 until July 20, 2015. The Agency is extending the comment period both for the draft standard MOU and for information collection issues under the PRA for 30 days, until July 20, 2015. The Agency believes that a 30-day extension allows adequate time for interested persons to submit comments without significantly delaying resolution of these important issues.


Please click here for additional information.











Association Management Software Powered by YourMembership  ::  Legal